Zhejiang Orient Gene Biotech Co., Ltd
Status: Publicly traded
Direct answer
Zhejiang Orient Gene Biotech Co., Ltd is publicly traded on SHH under the ticker 688298.SS.
Zhejiang Orient Gene Biotech Co., Ltd researches and develops, produces, and sells in vitro diagnostic products worldwide. Its products include POCT instant diagnostic reagents, used for detection of infectious diseases, drugs of abuse, fertility, tumor marker, and cardiac marker detection. The company offers its products for various categories, including COVID-19 diagnosis solutions; immunological diagnosis;...
Can you invest in Zhejiang Orient Gene Biotech Co., Ltd?
Yes. Zhejiang Orient Gene Biotech Co., Ltd trades publicly on SHH as 688298.SS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Zhejiang Orient Gene Biotech Co., Ltd
Detailed equity research is provided by MarketSnap.